Correlation Between Cumberland Pharmaceuticals and Arvinas

Can any of the company-specific risk be diversified away by investing in both Cumberland Pharmaceuticals and Arvinas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cumberland Pharmaceuticals and Arvinas into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cumberland Pharmaceuticals and Arvinas, you can compare the effects of market volatilities on Cumberland Pharmaceuticals and Arvinas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cumberland Pharmaceuticals with a short position of Arvinas. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cumberland Pharmaceuticals and Arvinas.

Diversification Opportunities for Cumberland Pharmaceuticals and Arvinas

-0.81

Correlation Coefficient

Cumberland Pharmaceuticals  Arvinas

Pay attention - limited upside

The 3 months correlation between Cumberland and Arvinas is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Cumberland Pharmaceuticals and Arvinas in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arvinas and Cumberland Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cumberland Pharmaceuticals are associated (or correlated) with Arvinas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arvinas has no effect on the direction of Cumberland Pharmaceuticals i.e., Cumberland Pharmaceuticals and Arvinas go up and down completely randomly.

Pair Corralation between Cumberland Pharmaceuticals and Arvinas

Given the investment horizon of 90 days Cumberland Pharmaceuticals is expected to generate 3.18 times more return on investment than Arvinas. However, Cumberland Pharmaceuticals is 3.18 times more volatile than Arvinas. It trades about 0.11 of its potential returns per unit of risk. Arvinas is currently generating about -0.08 per unit of risk. If you would invest  128.00  in Cumberland Pharmaceuticals on September 30, 2024 and sell it today you would earn a total of  104.00  from holding Cumberland Pharmaceuticals or generate 81.25% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Cumberland Pharmaceuticals  vs.  Arvinas

Cumberland Pharmaceuticals

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cumberland Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, Cumberland Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Arvinas

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Arvinas has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Cumberland Pharmaceuticals and Arvinas

The main advantage of trading using opposite Cumberland Pharmaceuticals and Arvinas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cumberland Pharmaceuticals position performs unexpectedly, Arvinas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will offset losses from the drop in Arvinas' long position.

The idea behind Cumberland Pharmaceuticals and Arvinas pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.